Esomeprazole Magnesium
Product Images NDC 68071-2590

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 68071-2590). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2590 6)

Label for Esomeprazole Magnesium 20mg delayed-release capsules by NuCare Pharmaceuticals, Inc. The label indicates a package count of 60 capsules, marked with 'H' on the cap and 'E2' on the body. Manufactured by Heritage Labs Limited, India. Includes warnings about keeping out of reach of children and storage temperature instructions.*

FDA Label Image

Esomeprazolemagnesiumfigure1 (Esomeprazolemagnesiumfigure1)

Chemical structure of esomeprazole magnesium showing its molecular components, including the magnesium ion complex with three water molecules.*

FDA Label Image

Esmoprazolemagnesiumfigure2 (Esomeprazolemagnesiumfigure2)

A line graph showing the percent maintained over a 6-month period for Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg doses, compared to placebo. The x-axis represents months from 0 to 6, and the y-axis shows percent maintained from 0 to 100.*

FDA Label Image

Esmoprazolemagnesiumfigure3 (Esomeprazolemagnesiumfigure3)

This is a line graph depicting the percent maintained over a six-month period for Esomeprazole Magnesium Delayed-Release Capsules at 40 mg and 20 mg dosages, a 10 mg dosage, and a placebo. The y-axis represents percent maintained from 0 to 100%, and the x-axis represents months from 0 to 6.*

FDA Label Image

Esomeprazolemagnesiumfigure4 (Esomeprazolemagnesiumfigure4)

A line graph showing the percentage of patients symptom-free over a 28-day diary period. It compares Esomeprazole Magnesium Delayed-Release Capsules at 40 mg and 20 mg doses with a placebo group. The vertical axis represents the percent of patients symptom-free, and the horizontal axis shows diary days from 0 to 28.*

FDA Label Image

Esomeprazolemagnesiumfigure5 (Esomeprazolemagnesiumfigure5)

A line graph depicting the percentage of patients symptom-free over 28 days of diary entries for three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, Esomeprazole Magnesium Delayed-Release Capsules 20 mg, and placebo. The x-axis represents diary days from 0 to 28, and the y-axis shows the percent of patients symptom-free ranging from 0 to 100%.*

FDA Label Image

Camber (Camber)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.